COL8A1 Predicts the Clinical Prognosis of Gastric Cancer and Is Related to Epithelial-Mesenchymal Transition

Table 5

The relationship between the expression of COL8A1 and clinicopathological characteristics.

COL8A1	Total; ()	Negative; ()	Positive; ()	value
Age (years)				0.905
	23 (19.3%)	7 (20.0%)	16 (19.0%)
	96 (80.7%)	28 (80.0%)	68 (81.0%)
Gender				0.692
Female	18 (15.1%)	6 (17.1%)	12 (14.3%)
Male	101 (84.9%)	29 (82.9%)	72 (85.7%)
Differentiation degree				0.922
Poorly	37 (31.1%)	11 (31.4%)	26 (31.0%)
Moderately	78 (65.5%)	23 (65.7%)	55 (65.5%)
Well	4 (3.4%)	1 (2.9%)	3 (3.6%)
Pathologic stage
I	8 (6.7%)	4 (11.4%)	4 (4.8%)	0.143
II	29 (24.4%)	10 (28.6%)	19 (22.6%)
III	64 (53.8%)	17 (48.6%)	47 (56.0%)
IV	18 (15.1%)	4 (11.4%)	14 (16.7%)
T stage
T1	1 (0.8%)	1 (2.9%)	0 (0%)	0.035
T2	13 (10.9%)	6 (17.1%)	7 (8.3%)
T3	49 (41.2%)	16 (45.7%)	33 (39.3%)
T4	56 (47.1%)	12 (34.3%)	44 (52.4%)
Lymph node status
N0	29 (24.4%)	10 (28.6%)	19 (22.6%)	0.030
N1	24 (20.2%)	11 (31.4%)	13 (15.5%)
N2	36 (30.3%)	11 (31.4%)	25 (29.8%)
N3	30 (25.2%)	3 (8.6%)	27 (32.1%)
Metastasis				0.565
M0	102 (85.7%)	31 (88.6%)	71 (84.5%)
M1	17 (14.3%)	4 (11.4%)	13 (15.5%)